Skip to content

Author

Hiroto Narimatsu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Clinical Benefit of Pembrolizumab in Lynch Syndrome‐Associated Advanced Ovarian Cancer With Germline MSH6 Variant: A Case Report

This case highlights the importance of genetic evaluation during treatment in young patients with advanced ovarian cancer. Lynch syndrome caused by a germline MSH6 pathogenic variant was diagnosed during first‐line maintenance therapy, and pembrolizumab achieved a durable response in recurrent disease.

Tomomi Yokozawa, Sayako Nakagawa, Yukio Suzuki et al. · 0 citations
Open access Sep 2026

Reassessing the public health value of regional cancer registries in the era of Japan’s National Cancer Registry: a learning health system perspective

Cancer registries are integral to public health infrastructure and support not only the monitoring of cancer incidence and mortality but also cancer control planning, quality assurance of screening programs, evaluation of healthcare delivery, prognostic assessment, and development of research infrastructure. Japan’s Na...

Hiroto Narimatsu, Kaname Watanabe, C. Chei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.